Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS

https://doi.org/10.17749/2070-4909.2016.9.1.079-083

Full Text:

Abstract

The article describes a new approach to the use of economic evaluation at the stage of planning and organization of clinical trials and considers the examples of studies which undertook this approach. The use of economic evaluation before clinical trials enables to assess the necessity of undertaking of the clinical trial and formulate the recommendations regarding the appropriate trial design, increasing its costeffectiveness.

About the Authors

N. Z. Musina
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation; Quality examination and control of medical products Centre of the Russian Federation Ministry of Health
Russian Federation

PhD, lecturer of the Department of Pharmacology, Pharmaceutical Faculty, ul. Trubetskaya, 8-2, Moscow, 119048;

Chief of development and communications, Center of Healthcare Quality Assessment and Control, Khokhlovsky per., 10-5, Moscow, 109028



V. V. Tarasov
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Head of the Department of Pharmacology, Pharmaceutical Faculty, ul. Trubetskaya, 8-2, Moscow, 119048


References

1. The Association of Clinical Research Organizations (ACTO). Information-analytical bulletin. URL: http://acto-russia.org/index.php?option=com_content&task=view&id=260. Accessed: 10.09.2015.

2. Omelyanovskiy V.V., Avksentyeva M.V., Derkach E.V., Sveshnikova N.D. Pediatricheskaya farmakologiya. URL: http://cyberleninka.ru/article/n/analiz-stoimosti-bolezni-problemy-i-puti-resheniya. Accessed: 10.09.2015.

3. Fund for the Advancement of Science, Education and Medicine. URL: http://fsrnom.ru/analytics/detail.php?ELEMENT_ID=239. Accessed: 10.09.2015.

4. Altman D.G. Practical statistics for medical research. New York. 1990; 455-61.

5. Berger M L., Bingefors K., Hedblom E.C. et al. Torrance Health care cost, quality and outcomes. ISPOR book of terms. Torrance. New York. 2003.

6. Drummond M.F., Sculpher M.J., Torrance G.W., O’Brien B.J. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford. 2005.

7. Gillespie W.J., Pekarsky B., O’Connel D.L. Evaluation of new technologies for total hip replacement: economic modeling and clinical trials. J Bone Joint Surg. 1995; 77B: 528-33.

8. Parsonett J., Harris R.A., Hack H.M., Owens D.K. Modelling cost effecriveness of Helicobacter screening to prevent gastric cancer: mandate for clinical trials. Lancet. 1996; 348: 150-4.

9. Torgerson P.D.J., Torgerson C.J. Designing Randomised trials in health, education and the social sciences: An introduction. United Kingdom. 2008; 108-111.

10. Trends, Charts, and Maps – ClinicalTrials.gov. 2015. URL: https://www.clinicaltrials.gov/ct2/resources/trends. Accessed: 10.09.2015.

11. Torgerson D.J., Byford S. Economic modelling before clinical trials. BMJ. 2002; 325: 98.


For citation:


Musina N.Z., Tarasov V.V. PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2016;9(1):79-83. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.1.079-083

Views: 313


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)